Nanotechnology : Maryland

2008 Johns Hopkins NanoBio Symposium - Hosted by the Institute for NanoBioTechnology

Admin — Mon, 17 Mar 2008 04:48:37 +0000

Short description

The second annual Johns Hopkins NanoBio Symposium will be held May 1-2, 2008 at the Johns Hopkins School of Medicine

Long description

The second annual Johns Hopkins NanoBio Symposium will be held May 1-2, 2008 at the Johns Hopkins School of Medicine

The Johns Hopkins NanoBio Symposium gathers experts involved in the study, training, research, development and commercialization of nanotechnology. Participants have the opportunity to hear about leading-edge technologies and recent scientific breakthroughs from experts using nanoscale solutions to solve problems in health care and medicine.

Nearly 400 people attended the 2007 NanoBio Symposium, and more than 100 posters were displayed. Due to the enthusiastic response, the 2008 event has been expanded to two days and includes a Thursday afternoon workshop with the theme “Nanotechnology for Cancer.”

On Friday morning, attendees will have the opportunity to hear talks by some of the world’s leading experts in nanobiotechnology. Friday afternoon’s poster session will feature a display of research projects representing departments from across the Johns Hopkins University, as well as from government and industrial entities.

Academic and clinical faculty, staff, students, representatives from government, business, industry, and the general public are invited to attend this enriching two-day event. Attendees also are invited to present posters, subject to INBT approval.

Invited speakers include:

* Donald E. Ingber, M.D., Ph.D. Judah Folkman Professor of Vascular Biology Department of Pathology, Harvard Medical School Vascular Biology Program, Children's Hospital (profile)
* Andrew D. Maynard, Ph.D. Chief Science Advisor, Project on Emerging Nanotechnologies Woodrow Wilson International Center for Scholars (profile)
* Paras N. Prasad, Ph.D. Distinguished Professor and Samuel P. Capen Chair of Chemistry Director, Institute for Lasers, Photonics, and Biophotonics University at Buffalo, The State University of New York
* Jeffery A. Schloss, Ph.D. Co-chair, Trans-NIH NANO Task Force Program Director, Technology Development Coordination National Human Genome Research Institute, National Institutes of Health (profile)
* Jennifer L. West, Ph.D. Isabel C. Cameron Professor of Bioengineering Rice University

Registration is required. JHU affiliated faculty, fellows, staff, and students may attend the symposium at NO COST. Non-JHU affiliated registrants pay a minimal fee. Registrants may also submit a poster, subject to approval by INBT.

Deadline for poster submissions is Thursday, April 17, 2008. Deadline for general registration without a poster submission is Thursday, April 24, 2008.

Thursday, May 1, 2008
Workshop: 2-5 p.m.
"Nanotechnology for Cancer"
Owens Auditorium
Hopkins Kimmel Cancer Center

Friday, May 2, 2008
Symposium: 9 a.m.-12:30 p.m.
Turner Auditorium
Hopkins School of Medicine

Poster Session: 2-4:30 p.m.
Turner Auditorium Concourse

Registration and poster submission form here: http://inbt.jhu.edu/documents/nanobio-symposium-registration.pdf

Event precise location and contact information

Web site Url link

Web site Url text

Neocera

vinay1210 — Thu, 27 Dec 2007 18:38:08 +0000

Ticker Id

Web url

http://www.neocera.com

Contact Email

harsh@neocera.com

Short description

Street address

10000 Virginia Manor Road

Zip or postal code

20705

Telephone

(800) 290-4322 x104

Fax

(301) 210-1042

Foundation date

Ceo, president

Number of employees

Long description

Founded in 1991 to commercialize technological expertise with ceramic thin films, Neocera has evolved into a leading-edge semiconductor and superconductor solutions provider. With more than 70 customers worldwide, Neocera's core values are: (1) to be extraordinarily attentive to and supportive of our customers, and (2) to inspire our employees by presenting them with ambitious goals and treating them with great respect.

Neocera Semiconductor

Neocera Semiconductor’s vision is to be the metrology and failure-analysis vendor that the world’s leading semiconductor manufacturers rely on for mission-critical needs. Our tools deliver advanced failure-analysis capabilities to semiconductor debug managers, FA labs, and next-generation process developers. Magma, our magnetic microscope quickly isolates failures in complex devices, resolves defects that other tools cannot, and minimizes time-to-market.

Neocera Thin Films

Neocera is a recognized world leader in the area of superconducting thin films. We are uniquely able to quickly deliver turn-key solutions for materials research, development and manufacturing. Our Pulsed Laser Deposition (PLD) and Pulsed Electron Deposition (PED) products deliver the highest-quality thin films for applications ranging from 3G microwave filters to nanomaterials to superconducting wire for urban power distribution.

Additional Commentaries and remarks

Patents

Avanti NanoSciences

Benj — Mon, 19 Nov 2007 20:26:26 +0000

Ticker Id

Web url

http://www.anano.at-gc.com/

Contact Email

Info@ANano.AT-GC.com

Short description

Street address

7720 Bel Air Road, Suite 200

Zip or postal code

21236

Telephone

301-540-5474

Fax

270-447-4777

Foundation date

Ceo, president

Number of employees

Long description

Avanti NanoSciences is focused on the Life Science market segments that consistently demand new and innovative technologies to further research, development and clinical capabilities.

These markets already represent a $32 billion opportunity that is rapidly growing based on the availability of new and innovative enabling technologies. Capturing market share with attractive and sustainable returns on investment is definitely achievable.

Despite their value, current technologies have significant limitations preventing their utility in broader research and diagnostic applications where rapid, accurate and cost-effective analysis of multi parameter testing is critical. Current immunological or PCR based methods do not provide a high level of sensitivity or reproducibility and are expensive and time-consuming. Various template amplification technologies provide sensitive and reproducible analysis but are limited to analyzing up to 4 to 5 genes at a time and thereby become prohibitively expensive for monitoring larger sets of expressed biomarkers.

Additional Commentaries and remarks

Patents

Phoenix S&T, Inc.

Benj — Mon, 02 Jul 2007 14:23:30 +0000

Ticker Id

Web url

http://www.phoenix-st.com/

Contact Email

Short description

Street address

107 Chesapeake Blvd. Suite 107

Zip or postal code

21921

Telephone

(410)996-9735

Fax

(410)996-9736

Foundation date

Ceo, president

Number of employees

Long description

Phoenix S&T's mission is to work closely with our customers to develop new applications. Even though the chips are targeted for protein applications, virtually any sample now analyzed by mass spectrometry can benefit from the superior performance of nanospray. We encourage all our potential users to contact us with ideas on how our devices may help you solve your problems in proteomics and other areas of applications.

Mission Statement

Phoenix S&T Inc. supplies 3-D microfluidic devices based on microinjection molding of plastics to provide highly flexible designs for a seamless integration into the customer's existing instruments and high-throughput robotics. These devices are groundbreaking in concept, have state-of-the-art performance and are easy to use and affordable. We are dedicated to helping our customers unleash the power of mass spectrometry analyses by working with them to provide the breakthrough technology needed to do their jobs faster, better and cheaper..

Additional Commentaries and remarks

Patents

SD Nanosciences, Inc.

Benj — Mon, 21 May 2007 15:29:27 +0000

Ticker Id

Web url

http://www.sdnanosciences.com/

Contact Email

info@sdnanosciences.com

Short description

Street address

8000 Virginia Manor Rd., Suite 140

Zip or postal code

20705

Telephone

301-706-1313

Fax

Foundation date

Ceo, president

Number of employees

Long description

SD Nanosciences, Inc. is a spin-off of the University of Maryland. Our proprietary "Triad" technology has applications in vaccines, cancer diagnostics, and specialty research probes. Triad combines carbohydrates and proteins on nanoparticles, which enables presentation of sugars and proteins in a controlled and logical way. We are developing our platform technology and our initial products include a vaccine for N meningitides B, an optical fiber-based point-of-care diagnostic test, and a biosensor for glycoprotein bioprocessing.

Additional Commentaries and remarks

Patents

University of Maryland : Complex fluids and nanomaterials group

Benj — Wed, 21 Mar 2007 11:31:06 +0000

Ticker Id

Web url

http://www.complexfluids.umd.edu/

Contact Email

Short description

Street address

Zip or postal code

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

Additional Commentaries and remarks

Patents

Tousims

Benj — Sat, 11 Nov 2006 12:16:44 +0000

Ticker Id

Web url

http://www.tousimis.com/

Contact Email

Short description

Street address

2211 Lewis Avenue

Zip or postal code

20851

Telephone

301.881.2450

Fax

301.881.5374

Foundation date

Ceo, president

Number of employees

Long description

tousimis research corporation (formerly Biodynamics Research Corporation) was organized in 1962 under the laws of the District of Columbia. Our company was founded to carry out basic research in areas related to the ultrastructure of matter and to correlate these findings with dynamic experiments. Our goal was, and still is, to develop and perfect instrumentation and products to be used in laboratories where similar studies are carried out. This idea (which has been the basis for our company for the past 41 years) was that of scientific pioneer Dr. A. J. Tousimis, President and CEO of tousimis research corporation.

Today we are pleased to present our listing of research chemicals, supplies, accessories, and instruments for the electron microscopy and analysis laboratory. The majority of items listed were developed in our laboratories where the demand for high quality and reliable instruments continues. We are aware that excellence in research requires not only the well prepared scientist and his organized scientific and technical team, but also the highest quality instrumentation, accessories, and supplies for reproducible and reliable results.

Additional Commentaries and remarks

Patents

NanoReg, Inc.

Benj — Sat, 11 Nov 2006 11:34:32 +0000

Ticker Id

Web url

http://www.nanoregnews.com/

Contact Email

johnd@nanoreg.net

Short description

Street address

14620 Dodie Terrace

Zip or postal code

20878

Telephone

(301) 987-0924

Fax

(301) 987-9094

Foundation date

Ceo, president

John DiLoreto

Number of employees

Long description

NanoReg, publisher of the NanoReg Report, is a professional services firm specializing in the application of laws and regulations related to the development and use of nanoscale materials throughout the nanotechnology value chain. John DiLoreto, NanoReg’s founder, has been instrumental in bringing together producers and users of nanoscale materials with government policy makers and non-governmental organizations to address growing environmental, health and safety concerns about the products of nanotechnology.

Mr. DiLoreto created and managed the American Chemistry Council’s Nanotechnology Panel which was the chemical industry’s first organized attempt to address scientific and regulatory issues related to nanoscale materials. As Director of the panel, an open dialogue was established with policymakers at the Environmental Protection Agency and the panel now enjoys a position as a key component in standard-setting discussions. Mr. DiLoreto’s experience managing chemical industry consortia provides an excellent resource for the NanoReg Report with a working knowledge of a wide range of chemical regulatory issues including TSCA (the Toxic Substances Control Act) and FIFRA (the Federal Insecticide, Fungicide and Rodenticide Act).

As a national leader in the effort to engage industry in nanotechnology environmental, health and safety (EHS) issues, Mr. DiLoreto has been recognized by Lux Research as a key player in the nanotechnology EHS debate and has been identified as an industry expert in its highly influential research reports. As a principle of NanoReg with a broad network of experienced regulatory and EHS professionals, he continues to work with nanotechnology firms and trade associations to assist companies in a variety of industrial sectors throughout the nanotechnology value chain.

With a history of working closely with producers and users of nanotechnology products and having established relationships with regulatory officials, NanoReg is uniquely qualified to identify key issues and participate in the multistakeholder dialogue that will eventually define regulatory requirements for nanoscale materials.

For additional information on the services provided by NanoReg, contact johnd@nanoreg.net or call (301) 987-0924.

Additional Commentaries and remarks

Patents

Shimadzu Scientific Instruments

Benj — Sat, 14 Oct 2006 16:29:38 +0000

Ticker Id

Web url

http://www.ssi.shimadzu.com/

Contact Email

Short description

Street address

7102 Riverwood Drive

Zip or postal code

21046

Telephone

1-800-477-1227

Fax

410-381-1222

Foundation date

Ceo, president

Number of employees

Long description

At Shimadzu, research and development represents the cornerstone of progress. From its inception, the Shimadzu Corporation has been investing resources to develop advanced technology to provide solutions for science, medicine, industry, and the environment. Many of our patented innovations have resulted in new discoveries and increased productivity, and have improved the quality of life the world over.

Today, Shimadzu continues the tradition as a global leader in the development of solutions for the world’s technology hurdles. In 2000, we established the Genomic Research Center in the U.K. and started contract biological analysis and trials for CO2 fixation technology. In 2001, we established life sciences laboratories in Kyoto and Tsukuba to carry out medium and long-term R&D for biological instruments and reagents. At the Technology Research Laboratories, which consists of five research centers located throughout Japan, we conduct research and development that results in original cutting-edge technology.

In addition, we actively pursue joint research opportunities with universities, large corporations like Bristol Myers Squibb, and government agencies like the National Institutes of Health (NIH).

Additional Commentaries and remarks

Patents

Intradigm Corporation

Benj — Sat, 02 Sep 2006 11:54:04 +0000

Ticker Id

Web url

http://www.intradigm.com/

Contact Email

info@intradigm.com

Short description

Street address

12115 Parklawn Drive, Suite K

Zip or postal code

20852

Telephone

(301)984-0185

Fax

(301)984-0186

Foundation date

Ceo, president

Number of employees

Long description

Intradigm is developing siRNA-derived cancer therapeutics utilizing its proprietary RNAi technology. Intradigm has led the advancement of siRNA from the test tube to a potent, tissue-targeted, systemically active therapeutic class of gene specific inhibitors. The Company believes that it is the first to demonstrate consistent and reproducible siRNA activity in animal disease models through targeted formulations of siRNA for systemic administration. Based upon the Company’s unique technology and capabilities for developing systemic tissue targeted formulations of siRNA and its ability to achieve efficacy in clinically relevant animal disease models, Intradigm has established an impressive cancer therapeutic product development program with its lead product, ICS-283, now in advanced pre-clinical development.

The Company’s initial focus is on siRNA inhibition of the VEGF pathway targeted to the angiogenic neovasculature. The siRNA formulated product can be used for the treatment of many serious diseases that result from excessive and unwanted angiogenesis, such as colon cancer, lung cancer and many other solid tumors as well as other angiogenesis based diseases such as ocular neovascularization. Intradigm has utilized its proprietary TargeTranÔ technology to develop siRNA formulations which can be systemically delivered and specifically targeted to neovasculature. This targeted, specific sequence siRNA, utilizing innovative layered nanoparticle technology, has been successfully evaluated in several angiogenesis disease animal models with demonstrated efficacy. Intradigm has identified colon cancer as the first indication to evaluate for its systemically administered VEGF pathway siRNA and expects to file an IND within the next 12 months.

In addition to its therapeutic product focus, Intradigm has taken advantage of its portfolio of in vivo siRNA technologies to establish a target validation service business to satisfy the growing demand for utilizing the Company’s powerful capabilities to achieve in vivo activity of RNAi. Intradigm currently has technology effective for a variety of local and systemic administration routes to offer pharmaceutical clients in their quest to validate their vast numbers of novel targets. Intradigm is rapidly expanding its repertoire of relevant animal models in which it has demonstrated siRNA activity for this in vivo target validation service. Intradigm will continue to expand these revenue generating collaborations in parallel with advancing development of its own therapeutic products.

Additional Commentaries and remarks

Patents

University of Maryland : Center for Nanomedicine and Cellular Delivery (CNCD)

Benj — Fri, 01 Sep 2006 15:03:56 +0000

Ticker Id

Web url

http://www.pharmacy.umaryland.edu/nanomedicine/

Contact Email

Short description

Street address

University of Maryland School of Pharmacy, Department of Pharmaceutical Sciences, 20 Penn Street, Room 625

Zip or postal code

21201

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

The convergence of recent advances in nanotechnology with modern biology and medicine has created the new research domain of nanobiotechnology. The use of nanobiotechnology in medicine is termed nanomedicine. Nanomedicine research includes the development of diagnostics for rapid monitoring, targeted cancer therapies, localized drug delivery, improved cell material interactions, scaffolds for tissue engineering, and gene delivery systems. Successful research and development in nanomedicine where ultimately patients can benefit from these new technologies require the interaction of a multitude of disciplines including material science and engineering, cellular biology and clinical translational research.

Additional Commentaries and remarks

Patents

ARVO : Nanotechnology and Nanomedicine: Applications for Vision course

Benj — Thu, 31 Aug 2006 15:33:57 +0000

Ticker Id

Web url

http://www.arvo.org/nano

Contact Email

Short description

Street address

The Association for Research in Vision and Ophthalmology (ARVO), 12300 Twinbrook Parkway, Suite 250

Zip or postal code

20852-1606

Telephone

240-221-2900

Fax

240-221-0370

Foundation date

Ceo, president

Number of employees

Long description

Organized by Drs. Paul Sieving and Richard Fisher of the NEI, the course features streaming video of speakers with their corresponding PowerPoint presentation slides. The seven-presentation course runs approximately three hours. Each presentation can be viewed separately and ranges from seven to 35 minutes in length. A online transcript of the course is also available.

The course introduces fundamental concepts, including changes in the properties of materials at the nanoscale, and the potential of nanotechnology and its application to biomedical sciences. The underlying physical sciences, conveyed by renowned experts in nanoscience, are emphasized and the course includes examples of NEI-funded studies of either applied or fundamental nanoscience in vision research.

Additional Commentaries and remarks

Patents

Hopkins University: Institute for Nanobiotechnology

Benj — Wed, 30 Aug 2006 16:22:52 +0000

Ticker Id

Web url

http://inbt.jhu.edu/

Contact Email

Short description

Street address

3400 North Charles Street

Zip or postal code

21218

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

The Institute's vision includes the development of innovative, interdisciplinary research programs focused in four interrelated thrust areas--therapeutics, diagnostics, cellular and molecular dynamics, and health and the environment. Interdisciplinary educational programs, public outreach programs, as well as industrial outreach programs at INBT are designed to foster the next generation of nanobiotechnology research and development.

Additional Commentaries and remarks

Patents

Nanotechnology Characterization Lab ( NCL )

Benj — Tue, 29 Aug 2006 18:57:19 +0000

Ticker Id

Web url

http://ncl.cancer.gov/

Contact Email

Short description

Street address

National Cancer Institute at Frederick, Attn: Nanotechnology Characterization Laboratory, P.O. Box B, Building 469, 1050 Boyles Street

Zip or postal code

21702-1201

Telephone

301-846-6939

Fax

301-846-6399

Foundation date

Ceo, president

Number of employees

Long description

The NCI believes that the NCL's activities will markedly speed the development of nanotechnology-based products for cancer patients, reduce the risk of doing so, and encourage private-sector investment in this promising area of technology development. By achieving its goals the NCL will provide a comprehensive set of baseline characterization parameters that will enable cancer biologists, drug and diagnostic developers, and clinical oncologists to apply their tools to solving problems that most affect cancer patients. This work will also lay a scientific foundation that will enable the FDA to make sound decisions concerning the testing and approval of nanoscale cancer diagnostics, imaging agents, and therapeutics.

To achieve its Mission, the NCL has established the following six objectives:

-Establish and Standardize an Analytical Cascade for Nanomaterial Characterization

-Facilitate the Clinical Development and Regulatory Review of Nanomaterials for Cancer Clinical Trials

-Identify and Characterize Critical Parameters Related to Nanomaterials' Absorption, Distribution, -Metabolism, Excretion, and Toxicity Profiles of Nanomaterials Using Animal Models

-Examine the Biological and Functional Characteristics of Multicomponent/Combinatorial Aspects of Nanoscaled Therapeutic, Molecular and Clinical Diagnostics, and Detection Platforms

-Engage and Facilitate Academic and Industrial-Based Knowledge Sharing of Nanomaterial Performance Data and Behavior Resulting from Pre-Clinical Testing

-Interface with Other Nanotechnology Efforts

Additional Commentaries and remarks

Patents

American Academy of Nanomedicine (AANM)

Benj — Mon, 28 Aug 2006 15:06:21 +0000

Ticker Id

Web url

http://www.aananomed.org/

Contact Email

Short description

Street address

P.O. Box 388

Zip or postal code

21770

Telephone

301-760-3402

Fax

718-535-2884

Foundation date

Ceo, president

Number of employees

Long description

The American Academy of Nanomedicine is a forum to exchange ideas, communicate new findings, and encourage collaboration among the diverse disciplines represented in Nanomedicine. Among other things, membership in AANM will provide you with:

-Access to the latest information in research and clinical applications through the society’s quarterly, peer-reviewed journal, Nanomedicine: Nanotechnology, Biology, and Medicine.

-The ability to discuss challenges and innovative findings with peers, face-to-face at AANM conferences, focused specifically on Nanomedicine-related topics and issues.

If you are involved in this exponentially expanding field as a basic or clinical investigator, engineer, molecular biologist, physician, or related profession of interest to the advancement of Nanomedicine, then let us know who you are so that we may keep you posted on upcoming events and initiatives.

Additional Commentaries and remarks

Patents

University of Maryland : Center for Integrated Nano Science and Engineering ( M-CINSE )

Benj — Sun, 27 Aug 2006 14:36:11 +0000

Ticker Id

Web url

http://www.nanocenter.umd.edu/

Contact Email

Short description

Street address

University of Maryland, Kim Building

Zip or postal code

20742

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

M-CINSE has been established as a partnership between three University of Maryland colleges: The A. James Clark School of Engineering, the College of Computer, Math, and Physical Sciences (CMPS), and the College of Life Sciences, with sustaining support from all three and the campus.

Led by founding director Gary W. Rubloff and Institute for Research in Electronics and Applied Physics (IREAP) Director Patrick O'Shea, M-CINSE promotes major nano research and education initiatives, provides one-stop shopping for those seeking expertise and/or partnerships at Maryland, and supplies infrastructure to facilitate nano activities at Maryland through equipment, staff support, and informational and administrative functions.

The mission of M-CINSE is to enhance the coherence and effectiveness of the University of Maryland nano community through a strategy based on:

-coordinating shared state-of-art experimental facilities;
-developing best practices for administrative infrastructure supports;
-providing coherent, broad visibility at state, national, and international levels;
-encouraging and facilitating nano program growth and fund-raising;
-guiding the evolution of coordinated educational programs for the nano workforce of the future;
-promoting the development and transfer of nanotechnology and related intellectual property to the marketplace.

Additional Commentaries and remarks

Patents

Colossal Storage Corp.

Benj — Thu, 24 Aug 2006 15:31:16 +0000

Ticker Id

Web url

http://colossalstorage.net/

Contact Email

Short description

Street address

506 4th Street

Zip or postal code

21851

Telephone

410-957-1990

Fax

Foundation date

Ceo, president

Number of employees

Long description

Colossal Storage knows the invention and patents by Michael E. Thomas on a technique for changing matter at the molecular level is one of the World's only NEW enabling technologies having hundreds of electro-optic applications in which a few are discussed on our other applications of Patented Technology webpage .
Atomic Holographic Nanotechnology will allow for the first time a functional method for programmable molecular lenses that will allow incoming light to be rejected, modified internally, or allowed to pass un altered thru a transparent lens known as disk, tape, card, drum, film, plate, etc.

By being able to use plasmonic physics to program optical lenses many applications based on light and color can be developed like holographic data storage, bio-terror detection devices, optical electronics, OLED displays, and spintronic data storage. Michael E. Thomas has invented and patented a mankind first and only concept for non-contact UV photon induced electric field poling of ferroelectric non-linear photonic bandgap crystals which offers the possibility of controlling and manipulating light within a UV/Deep Blue frequency of 1 nm to 400 nm.

The small size of ferroelectric transparent structures makes it possible to fabricate nano-optical devices like volume holographic storage having both positive and negative index of refraction that will allow molecular particles of an atomic size to be modified, controlled, and changed to perform a specific function, desired task, used for low cost accurate chemical / biological matter detection, and reprogrammed to accept new non-volatile data and molecular functions.

Additional Commentaries and remarks

Patents

Johns Hopkins University: Materials Research Science and Engineering Center (MRSEC)

Benj — Thu, 24 Aug 2006 13:19:14 +0000

Ticker Id

Web url

http://www.pha.jhu.edu/groups/mrsec/index.html

Contact Email

Short description

Street address

Johns Hopkins University MRSEC, c/o Ms. Jane Callahan, Department of Physics and Astronomy, 3400 N. Charles St.

Zip or postal code

21218

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

Research in the Center focuses on nanostructures made from novel materials that exhibit enhanced magneto-electronic properties. These include:

Materials with high spin polarization, especially half-metallic ferromagnets.

Materials with long carrier mean free path and spin diffusion lengths.

Heterogeneous layers that exhibit interfacial phenomena.
Multi-section quasi one-dimensional structures.

Lithographically patterned arrays of dots, antidots, nanowires, and other structures.

Nanowires with multi-functionality for chemical and biological applications.

The research effort encompasses synthesis and processing, characterization of nanostructures, measurements of properties, theoretical modeling, and prototype device fabrication and applications.

These five tightly linked components form the research basis of this MRSEC.

The JHU MRSEC also has extensive Education Outreach programs and extensive collaborations with other academic institutions, national labs, and industrial concerns.

Additional Commentaries and remarks

Patents

Johns Hopkins University: Mechanical Engineering

Benj — Thu, 24 Aug 2006 13:16:54 +0000

Ticker Id

Web url

http://pegasus.me.jhu.edu/

Contact Email

Short description

Street address

The Johns Hopkins University, Department of Mechanical Engineering, 223 Latrobe Hall, 3400 North Charles Street

Zip or postal code

21218-2681

Telephone

Fax

Foundation date

Ceo, president

Number of employees

Long description

Our mission is to be small but superb: our faculty are the intellectual leaders in their respective fields of research, and we offer our students the opportunity to work one-on-one with the faculty in advancing the frontiers of knowledge. We believe in the founding vision of Daniel Coit Gilman, the first President of Johns Hopkins: "The best teachers are usually those that are impassioned by their research, and the best researchers are usually those that are invigorated by the intellectual stimulation provided by their students. The Department emphasizes the development of a close-knit, collegial and stimulating environment for the free development and exchange of ideas, particularly in areas of interdisciplinary research.

Additional Commentaries and remarks

Patents

CytImmune Sciences, Inc.

Benj — Tue, 22 Aug 2006 18:48:51 +0000

Ticker Id

Web url

http://www.cytimmune.com/

Contact Email

info@cytimmune.com

Short description

Street address

9640 Medical center drive

Zip or postal code

20850

Telephone

(240)864-2796

Fax

(301)315-2438

Foundation date

Ceo, president

Number of employees

Long description

The use of colloidal gold as a human therapeutic dates back to the 1930's when it was shown to temporarily relieve joint inflammation associated with rheumatoid arthritis.Yet the lack of understanding of its mechanism of action has limited its therapeutic potential. The Company believes that the potential for colloidal gold in medicine is very broad, and, through an aggressive patent strategy the Company will seek to capture both its therapeutic and commercial potential.

The Company made a rather surprising observation: animals injected with native cytokine exhibited strong toxicological responses, whereas animals receiving injections of cytokines bound to colloidal gold did not. This singular observation lead us to conclude that colloidal gold may be a universal, clinically safe, commercially sound drug/gene delivery system.